Michael Farris, MD
- Assistant Professor, Radiation Oncology

Michael Farris, MD
- Education
- MD, State University of New York Upstate Medical University at Syracuse, 2013
- Residency
- Radiation Oncology, Wake Forest University School of Medicine, 0001
- Internal Medicine, Carilion Clinic-Roanoke Memorial Hospital, 2014
- Board Certifications
- American Board of Radiolog, American Board of Radiology
- American Board of Radiology, American Board of Radiology
- American Board of Radiology - Radiation Oncology
- Positions
- Assistant Professor, Radiation Oncology
- Departments and Affiliations
- Radiation Oncology
- Comprehensive Cancer Center
Research
- Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience. Hughes RT, Masters AH, McTyre ER, Farris MK, Chung C, Page BR, Kleinberg LR, Hepel J, Contessa JN, Chiang V, Ruiz J, Watabe K, Su J, Fiveash JB, Braunstein S, Chao S, Attia A, Ayala-Peacock DN, Chan MD. Int. J. Radiat. Oncol. Biol. Phys. 2019 08; 104(5):1091-1098.
- Simple and Rapid Creation of Customized 3-dimensional Printed Bolus Using iPhone X True Depth Camera. LeCompte MC, Chung SA, McKee MM, Marshall TG, Frizzell B, Parker M, Blackstock AW, Farris MK. Pract Radiat Oncol. ; 9(4):e417-e421.
- Does Stereotactic Radiosurgery Have a Role in the Management of Patients Presenting With 4 or More Brain Metastases?. Soike MH, Hughes RT, Farris M, McTyre ER, Cramer CK, Bourland JD, Chan MD. Neurosurgery. 2019 03; 84(3):558-566.
- Analysis of the drivers of cost of management when patients with brain metastases are treated with upfront radiosurgery. Shenker RF, McTyre ER, Taksler GB, D'Agostino RB, Cramer CK, Ruiz J, Alphonse-Sullivan NK, Farris M, Watabe K, Xing F, Laxton AW, Tatter SB, Chan MD. Clin Neurol Neurosurg. 2019 01; 176:10-14.
- Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature. Farris M, Hughes RT, Lamar Z, Soike MH, Menke JR, Ohgami RS, Winkfield K. Clin Lymphoma Myeloma Leuk. 2019 01; 19(1):e1-e8.